Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Study of hepatoprotective effects of xymedon.
Vyshtakalyuk AB, Nazarov NG, Zueva IV, Lantsova AV, Minnekhanova OA, Busygin DV, Porfiryev AG, Evtyugin VG, Reznik VS, Zobov VV. Vyshtakalyuk AB, et al. Bull Exp Biol Med. 2013 Sep;155(5):643-6. doi: 10.1007/s10517-013-2215-0. Bull Exp Biol Med. 2013. PMID: 24288729
Pirimidine derivatives as hepatoprotective agents.
Vyshtakalyuk AB, Nazarov NG, Zobov VV, Semenov VE, Galyametdinova IV, Tcherepnev GV, Reznic VS. Vyshtakalyuk AB, et al. Int J Risk Saf Med. 2015;27 Suppl 1:S78-9. doi: 10.3233/JRS-150698. Int J Risk Saf Med. 2015. PMID: 26639723
Delivery nanosystems based on sterically hindered phenol derivatives containing a quaternary ammonium moiety: Synthesis, cholinesterase inhibition and antioxidant activity.
Pashirova TN, Burilova EA, Tagasheva RG, Zueva IV, Gibadullina EM, Nizameev IR, Sudakov IA, Vyshtakalyuk AB, Voloshina AD, Kadirov MK, Petrov KA, Burilov AR, Bukharov SV, Zakharova LY. Pashirova TN, et al. Among authors: vyshtakalyuk ab. Chem Biol Interact. 2019 Sep 1;310:108753. doi: 10.1016/j.cbi.2019.108753. Epub 2019 Jul 15. Chem Biol Interact. 2019. PMID: 31319075
Bi-functional sterically hindered phenol lipid-based delivery systems as potential multi-target agents against Alzheimer's disease via an intranasal route.
Burilova EA , Pashirova TN , Zueva IV , Gibadullina EM , Lushchekina SV , Sapunova AS , Kayumova RM , Rogov AM , Evtjugin VG , Sudakov IA , Vyshtakalyuk AB , Voloshina AD , Bukharov SV , Burilov AR , Petrov KA , Zakharova LY , Sinyashin OG . Burilova EA , et al. Among authors: vyshtakalyuk ab. Nanoscale. 2020 Jul 2;12(25):13757-13770. doi: 10.1039/d0nr04037a. Nanoscale. 2020. PMID: 32573587
20 results